Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
MTE 30 - Cachexia (Ticketed Session)
- Type: Meet the Expert (Ticketed Session)
- Track: Palliative and Supportive Care
- Presentations: 2
- Coordinates: 9/09/2015, 07:00 - 08:00, 702+704+706
-
+
MTE30.01 - Cachexia
07:00 - 07:30 | Author(s): A. Abernethy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE30.02 - Cachexia
07:30 - 08:00 | Author(s): J. Crawford
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 31 - Smoking Cessation Integrated with Screening (Window of Opportunity) (Ticketed Session)
- Type: Meet the Expert (Ticketed Session)
- Track: Prevention and Tobacco Control
- Presentations: 2
- Coordinates: 9/09/2015, 07:00 - 08:00, 708+710+712
-
+
MTE31.01 - Smoking Cessation Integrated with Screening (Window of Opportunity)
07:00 - 07:30 | Author(s): D.R. Aberle
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE31.02 - Smoking Cessation Integrated with Screening (Window of Opportunity)
07:30 - 08:00 | Author(s): J. Ostroff
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 32 - Treatment of Early Stage SCLC (Ticketed Session)
- Type: Meet the Expert (Ticketed Session)
- Track: Small Cell Lung Cancer
- Presentations: 2
- Coordinates: 9/09/2015, 07:00 - 08:00, 703
-
+
MTE32.01 - Treatment of Early Stage SCLC
07:00 - 07:30 | Author(s): J. Jassem
- Abstract
Loading... -
+
MTE32.02 - Treatment of Early Stage SCLC
07:30 - 08:00 | Author(s): E. Lim
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 33 - (Debate on) Prognostic Biomarkers in Mesothelioma (Ticketed Session)
- Type: Meet the Expert (Ticketed Session)
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 2
- Coordinates: 9/09/2015, 07:00 - 08:00, 201+203
-
+
MTE33.01 - (Debate on) Prognostic Biomarkers in Mesothelioma
07:00 - 07:30 | Author(s): R. Bueno
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE33.02 - (Debate on) Prognostic Biomarkers in Mesothelioma
07:30 - 08:00 | Author(s): B.W.S. Robinson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PLEN 03 - Science Drives Lung Cancer Advances
- Type: Plenary
- Track: Plenary
- Presentations: 6
- Moderators:T. Mitsudomi
- Coordinates: 9/09/2015, 08:15 - 09:45, Plenary Hall (Bellco Theatre)
-
+
Introduction
08:15 - 08:20
- Abstract
No abstract available for this presentation
-
+
PLEN03.01 - Lung Cancer Genomes - Adenocarcinoma
08:20 - 08:35 | Author(s): M. Meyerson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.02 - Lung Cancer Genomes - Squamous Cell Carcinoma/Small Cell
08:35 - 08:50 | Author(s): R.K. Thomas
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.03 - Molecular Mechanisms of Drug Resistance
08:50 - 09:10 | Author(s): P.A. Jänne
- Abstract
No abstract available for this presentation
-
+
PLEN03.04 - Personalized Medicine
09:10 - 09:30 | Author(s): J. Remon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PLEN03.05 - Mouse Models of SCLC and NSCLC
09:30 - 09:50 | Author(s): A. Berns
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-001 - Imprime PGG, a Novel Innate Immune Modulator, Combined with Carboplatin, Paclitaxel and Bevacizumab for 1st Line Advanced Nonsquamous NSCLC
09:30 - 09:30 | Author(s): W. Engel-Reidel
- Abstract
Loading... -
+
P3.01-002 - PD-L1 Expression and FGFR1 Amplification in Chinese Stage III/IV Lung Squamous Carcinoma
09:30 - 09:30 | Author(s): J. Wang
- Abstract
Loading... -
+
P3.01-003 - Patterns of Disease Progression for Stage IV NSCLC While on PD-1 Directed Therapy as Compared to Standard Chemotherapy
09:30 - 09:30 | Author(s): M.S. Chatwal
- Abstract
Loading... -
+
P3.01-004 - Paxillin Confers Resistance to TKI via Modulating BIM and Mcl-1 Protein Stability
09:30 - 09:30 | Author(s): H. Lee
- Abstract
Loading... -
+
P3.01-005 - Clinical Effects of Icotinib for Brain Metastasis in Chinese Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation
09:30 - 09:30 | Author(s): H. Hou
- Abstract
Loading... -
+
P3.01-006 - Propensity Score Matched Comparison of EGFR TKI for EGFR Mutation 19del vs 21L858R
09:30 - 09:30 | Author(s): Z. Zhou
- Abstract
Loading... -
+
P3.01-007 - Evaluation of Gefitinib Efficacy According to Body Surface Area, Body Weight, and Body Mass Index in Patients with NSCLC Harboring EGFR Mutations
09:30 - 09:30 | Author(s): R. Sakurai
- Abstract
Loading... -
+
P3.01-008 - Gefitinib in Front-Line Treatment of 161 Caucasian Patients with NSCLC of the Czech Republic
09:30 - 09:30 | Author(s): J. Skrickova
- Abstract
Loading... -
+
P3.01-009 - Impact of EGRR Mutation on Brain Metastasis and Disease-Free Survival in Patients with Surgically Resected Lung Adenocarcinoma
09:30 - 09:30 | Author(s): T. Akita
- Abstract
Loading... -
+
P3.01-010 - Multivariate Survival Analysis of China IRESSA Charitable Aid Project in Shanghai
09:30 - 09:30 | Author(s): H. Jian
- Abstract
Loading... -
+
P3.01-011 - Antitumor Activity of Tepotinib plus Gefitinib in Asian Patients with Met+ EGFRm+ NSCLC
09:30 - 09:30 | Author(s): D. Kim
- Abstract
Loading... -
+
P3.01-012 - Efficacy of Chemotherapy after First-Line Gefitinib for EGFR-Mutant NSCLC Patients
09:30 - 09:30 | Author(s): T. Kuwako
- Abstract
Loading... -
+
P3.01-013 - Combination of Chemotherapy and Gefitinib as First-Line Treatment of Patients with Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations
09:30 - 09:30 | Author(s): B. Jin
- Abstract
Loading... -
+
P3.01-014 - Interleukin-6 Is a Valuable Predictive Marker for Therapeutic Effect of Gefitinib in Patients with Advanced NSCLC Harboring EGFR Mutations
09:30 - 09:30 | Author(s): Y. Kato
- Abstract
Loading... -
+
P3.01-015 - Efficacy, Safety and Dosage of Afatinib in Patients with NSCLC after Failure of Prior EGFR-TKI
09:30 - 09:30 | Author(s): Y. Kim
- Abstract
Loading... -
+
P3.01-016 - Does Sequence of Cranial Radiotherapy Matter in EGFR Mutant Non-Small Cell Lung Cancer Patients with Brain Metastasis?
09:30 - 09:30 | Author(s): S. Byeon
- Abstract
Loading... -
+
P3.01-017 - P53 Disruptive Mutation Is a Negative Predictive Factor in EGFR M+ NSCLC Treated with TKIEfficacy and Safety of Gefitinib for Elderly Patients with EGFR Mutation Positive NSCLC
09:30 - 09:30 | Author(s): K. Kusaka
- Abstract
Loading... -
+
P3.01-018 - Icotinib for Control of Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer with Sensitive EGFR Mutations
09:30 - 09:30 | Author(s): Y. Fan
- Abstract
Loading... -
+
P3.01-019 - Treatment and Clinical Evolution of a Cohort of 105 EGFR Mutant Patients from a Single Institution
09:30 - 09:30 | Author(s): H.C. Freitas
- Abstract
Loading... -
+
P3.01-020 - Updated Data from JP28927 Study of Alectinib in ALK+ NSCLC Patients with or without History of ALK Inhibitor Treatment
09:30 - 09:30 | Author(s): K. Hotta
- Abstract
Loading... -
+
P3.01-021 - New Perspectives for the Patients with ALK Positive Lung Adenocarcinomas, after Failure of Crizotinib Therapy. A Single Institution Experience
09:30 - 09:30 | Author(s): M. Pesek
- Abstract
Loading... -
+
P3.01-022 - A Prospective Multicenter Study for ALK IHC+ Metastasized NSCLC
09:30 - 09:30 | Author(s): E. Thunnissen
- Abstract
Loading... -
+
P3.01-023 - A Phase II Trial of AUY922, a Heat Shock Protein 90 (HSP90) Inhibitor, in ALK-Positive Lung Cancer Patients Previously Treated with ALK Inhibitors
09:30 - 09:30 | Author(s): J.F. Gainor
- Abstract
Loading... -
+
P3.01-024 - The Effect of Pemetrexed as First Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer with Anaplastic Lymphoma Kinase Gene Rearrangements
09:30 - 09:30 | Author(s): D. Ma
- Abstract
Loading... -
+
P3.01-025 - Real-Life Experience and Clinical Characterization in Patients with ALK Positive NSCLC: A Multicentre Study of the Austrian Lung Cancer Group
09:30 - 09:30 | Author(s): M.J. Hochmair
- Abstract
Loading... -
+
P3.01-026 - Short-Term Efficacy of Helical Tomotherapy in the Treatment of Intracranial Multiple Brain Metastases of Lung Cancer
09:30 - 09:30 | Author(s): F. Wang
- Abstract
Loading... -
+
P3.01-027 - Lung Adenocarcinoma in Patients from the Colombian Coffee Zone
09:30 - 09:30 | Author(s): G. Rojas
- Abstract
Loading... -
+
P3.01-028 - Serum Levels of C-Reactive Protein Predict Poor Outcome of Patients with Advanced-Stage NSCLC Treated with Erlotinib
09:30 - 09:30 | Author(s): O. Fiala
- Abstract
Loading... -
+
P3.01-029 - Factors Impacting Delay in Timely Care for Patients Diagnosed with Lung Cancer in Victoria
09:30 - 09:30 | Author(s): S. Evans
- Abstract
Loading... -
+
P3.01-030 - Multimodality Treatment for Non-Small Cell Lung Cancer with Ipsilateral Pleural Dessimination
09:30 - 09:30 | Author(s): A. Kurchenkov
- Abstract
Loading... -
+
P3.01-031 - Prognosis Factors in Stage IV Lung Adenocarcinoma with Single Brain Metastasis
09:30 - 09:30 | Author(s): L. Miron
- Abstract
Loading... -
+
P3.01-032 - Near Infrared Photoimmunotherapy for Pleural Metastases: Preclinical Experience
09:30 - 09:30 | Author(s): K. Sato
- Abstract
Loading... -
+
P3.01-033 - Comparison of Symptom Score and Bronchoscopy Based Assessment with Conventional CT Based Assessment of Response to Chemotherapy in Lung Cancer
09:30 - 09:30 | Author(s): D. Behera
- Abstract
Loading... -
+
P3.01-034 - Long-Term Survival in Metastatic Non-Small Cell Lung Cancer: Predictive Clinical Factors
09:30 - 09:30 | Author(s): L.A. Boente
- Abstract
Loading... -
+
P3.01-035 - Treatment of NSCLC Patients by Community Health Practitioners: Practice Pattern and Competence Assessments
09:30 - 09:30 | Author(s): M.N. Becker
- Abstract
Loading... -
+
P3.01-036 - The Safety and Efficacy of Thoracic Reirradiation
09:30 - 09:30 | Author(s): M.W. Straza
- Abstract
Loading... -
+
P3.01-037 - Impact of Endobronchial Stents on Patients with NSCLC and Central Airway Obstruction (CAO)
09:30 - 09:30 | Author(s): N. Abdel Karim
- Abstract
Loading... -
+
P3.01-038 - Comparing Next-Generation Sequencing (NGS) Platforms in Patients with Thoracic Tumors: Tumor Tissue vs. Circulating Cell-Free DNA from Blood
09:30 - 09:30 | Author(s): M.L. Johnson
- Abstract
Loading... -
+
P3.01-039 - Patient Characteristics and Treatment Outcome of Advanced Non-Squamous NSCLC with over 6-Month Disease Control from Icotinib
09:30 - 09:30 | Author(s): S. Yang
- Abstract
Loading... -
+
P3.01-040 - Prospective Evaluation of Changes in Cancer Cachexia in NSCLC in Patients given Chemotherapy by Correlating Skeletal Muscle Mass with PRO Results
09:30 - 09:30 | Author(s): R.D. Gentzler
- Abstract
Loading... -
+
P3.01-041 - Treatment Beyond Second Line Chemotherapy Outside of a Clinical Trial Is Appropriate for Selected NSCLC Patients
09:30 - 09:30 | Author(s): A.A. Badawy
- Abstract
Loading... -
+
P3.01-042 - Neutrophilia and Lymphopenia Can Be Prognostic Factors in Non-Small Cell Lung Cancer with Adenocarcinoma Histology
09:30 - 09:30 | Author(s): J. Jeong
- Abstract
Loading... -
+
P3.01-043 - Assessing Treatment Strategies for Lung Cancer in Octogenarians: Insights From a Cohort of 337 Patients
09:30 - 09:30 | Author(s): V. Zarza
- Abstract
Loading... -
+
P3.01-044 - FDG-PET/CT Based Response Prediction of Stage IV NSCLC Treated with Paclitaxel-Carboplatin-Bevacizumab with or without Nitroglycerin
09:30 - 09:30 | Author(s): E.E.C. De Jong
- Abstract
Loading... -
+
P3.01-045 - Short-Term Outcomes of Stage IV Non-Small Cell Lung Cancer with Brain Metastasis
09:30 - 09:30 | Author(s): S.K. Hwang
- Abstract
Loading... -
+
P3.01-046 - Pleural Photodynamic Therapy in Pleural Metastasis by Lung Cancer
09:30 - 09:30 | Author(s): K. Chen
- Abstract
Loading... -
+
P3.01-047 - Weekly Paclitaxel plus Bevacizumab in Heavily Pre-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P3.01-048 - Predictors of Subsequent Lines of Therapy (LOTs) in Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): E. Nadler
- Abstract
Loading... -
+
P3.01-049 - Concomitant Chemoradiotherapy with Etoposide & Cisplatin versus Docetaxel & Cisplatin in Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Eralp
- Abstract
Loading... -
+
P3.01-050 - A Interim Analysis of Randomized Phase III Trial of Nedaplatin or Cisplatin Combined with Docetaxel as First-Line Treatment for Advanced ASQC
09:30 - 09:30 | Author(s): S. Lu
- Abstract
Loading... -
+
P3.01-051 - Biomarker Analyses from a Phase II Trial of Nab-Paclitaxel/Carboplatin vs Emcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Yang
- Abstract
Loading... -
+
P3.01-052 - Randomized Phase II Individualized Chemotherapy Study Based on BRCA1 and RRM1 Message RNA Level for Advanced NSCLC (BRAVO Study)
09:30 - 09:30 | Author(s): G. Gao
- Abstract
Loading... -
+
P3.01-053 - Efficacy and Safety of Extended Therapy with Endostar Combined with Chemotherapy in Patients with Advanced NSCLC: A Retrospective Study
09:30 - 09:30 | Author(s): W. Hu
- Abstract
Loading... -
+
P3.01-054 - Etirinotecan Pegol (NKTR-102) in the Treatment of Patients with Metastatic NSCLC after Failure of 2nd Line Treatment: A Phase II Study
09:30 - 09:30 | Author(s): C. Aggarwal
- Abstract
Loading... -
+
P3.01-055 - Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)
09:30 - 09:30 | Author(s): S. Vazquez
- Abstract
Loading... -
+
P3.01-056 - Phase II Study of Carboplatin plus Weekly Nab-Paclitaxel in Elderly Patients with NSCLC: North Japan Lung Cancer Study Group Trial 1301
09:30 - 09:30 | Author(s): O. Ishimoto
- Abstract
Loading... -
+
P3.01-057 - Randomized Phase 2 Study of Plinabulin and Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer - Mechanism-Based Efficacy Analyses
09:30 - 09:30 | Author(s): L. Bazhenova
- Abstract
Loading... -
+
P3.01-058 - nab-Paclitaxel + Carboplatin in Advanced Non-Small Cell Lung Cancer NSCLC: Dose Modification Analysis
09:30 - 09:30 | Author(s): P.E. Postmus
- Abstract
Loading... -
+
P3.01-059 - Treatment Intensity and Duration in Patients Receiving First-Line Nab-paclitaxel or Paclitaxel (Weekly or Every 3 weeks) for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis Utilizing Electronic Medical Records
09:30 - 09:30 | Author(s): J. Weiss
- Abstract
Loading... -
+
P3.01-060 - Prognostic Value of Serum Proteomic Test and of Comorbidity Index in Diversified Population with Lung Cancer
09:30 - 09:30 | Author(s): A.Z. Dudek
- Abstract
Loading... -
+
P3.01-061 - A Prognostic Model for Platinum-Doublet Regimens as Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading... -
+
P3.01-062 - Impact of Gender on Survival Outcome in Saudi Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): H. Eltaani
- Abstract
Loading... -
+
P3.01-063 - Development of a Patient-Reported Outcome (pro) Assessment of Core Non-Small Cell Lung Cancer (NSCLC) Symptoms
09:30 - 09:30 | Author(s): K. Debusk
- Abstract
Loading... -
+
P3.01-064 - Erlotinib in EGFR-Positive NSCLC: Efficacy, Safety and Feasibility for Rebiopsy
09:30 - 09:30 | Author(s): M. Trigo
- Abstract
Loading... -
+
P3.01-065 - PET Tumor Response by PERCIST Predicts Local-Regional Control in Locally Advanced NSCLC after Concurrent Chemoradiotherapy with Erlotinib
09:30 - 09:30 | Author(s): X. Wei
- Abstract
Loading... -
+
P3.01-066 - Bevacizumab Combined with Docetaxel : A Real Active Second Line Regimen in Elderly Patients with Advanced Non-Small Cell Cancer (NSCLC)
09:30 - 09:30 | Author(s): S. Abdelwahab
- Abstract
Loading... -
+
P3.01-067 - Pemetrexed (P)/Carboplatin/Bevacizumab (B) Followed by Maintenance P/B in Hispanic Patients with Non-Squamous NSCLC
09:30 - 09:30 | Author(s): L. Rojas
- Abstract
Loading... -
+
P3.01-068 - Phase II Study of S-1 plus Bevacizumab for Pretreated Patients with Non-Squamous NSCLC
09:30 - 09:30 | Author(s): K. Yamada
- Abstract
Loading... -
+
P3.01-069 - Phase II Trial of Paclitaxel, Irinotecan, and Bevacizumab for Patients with Untreated NSCLC Overexpressed ERCC1 MRNA; Evaluated by EBUS-GS
09:30 - 09:30 | Author(s): Y. Nakamaura
- Abstract
Loading... -
+
P3.01-070 - Experience with Docetaxel plus Nintedanib with Previously Treated NSCLC Patients: Compassionate Use Program Single Institution in Mexico
09:30 - 09:30 | Author(s): S. Campos-Gomez
- Abstract
Loading... -
+
P3.01-071 - RAS Inhibitor Prevent Proteinuria of NSCLC Patients Who Received Bevasizumab Chemotherapy: NJLCG 1303
09:30 - 09:30 | Author(s): S. Kuyama
- Abstract
Loading... -
+
P3.01-072 - Final Efficacy and Safety Results of ECOG Performance Status (PS) Subgroup Analyses From the SQUIRE Phase III Study
09:30 - 09:30 | Author(s): M.A. Socinski
- Abstract
Loading... -
+
P3.01-073 - Nimotuzumab in Advanced Squamous Cell Lung Cancer: A 2 Year Comparative Indian Clinical Experience
09:30 - 09:30 | Author(s): G. Babu
- Abstract
Loading... -
+
P3.01-074 - Phase I-II Trial of Combined PKC Iota and mTOR Inhibition for Patients with Advanced or Recurrent Lung Cancer - A Trial in Progress
09:30 - 09:30 | Author(s): H.J. Ross
- Abstract
Loading... -
+
P3.01-075 - Phase 2 Trial of Bortezomib in KRAS G12D Mutant Lung Cancers
09:30 - 09:30 | Author(s): G.J. Riely
- Abstract
Loading... -
+
P3.01-076 - Efficacy and Safety of Recombinant Human Tumor Necrosis Factor Application for the Treatment of Malignant Pleural Effusion Caused by Lung Cancer
09:30 - 09:30 | Author(s): Q. Li
- Abstract
Loading... -
+
P3.01-077 - A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum- Based Chemotherapy
09:30 - 09:30 | Author(s): H.R. Kim
- Abstract
Loading... -
+
P3.01-078 - Avelumab (MSB0010718C), an Anti-PD-L1 Antibody, Evaluated in a Phase III Trial versus Docetaxel in Patients with Relapsing NSCLC
09:30 - 09:30 | Author(s): K. Park
- Abstract
Loading... -
+
P3.01-079 - Addition of Hsp27 Inhibitor Apatorsen to First-Line Gemcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer: Design of the Cedar™ Trial
09:30 - 09:30 | Author(s): P. Schmid
- Abstract
Loading... -
+
P3.01-080 - An Open-Label, Multicenter, Phase 1b/2 Study to Evaluate Necitumumab in Combination with Gemcitabine and Cisplatin in the First-Line Treatment of Patients with Advanced (Stage IV) Squamous Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): T. Tamura
- Abstract
Loading... -
+
P3.01-081 - Navotrial 3: Oral Vinorelbine + Cisplatin (P) vs Gemcitabine + P in 1st Line Advanced Squamous Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): P. Jaskiewicz
- Abstract
Loading... -
+
P3.01-082 - Multicenter Randomized Trial Comparing Erlotinib vs. Gemcitabine or Vinorelbine as Third-Line in Advanced EGFR-Wild-Type or Unknown NSCLC
09:30 - 09:30 | Author(s): M. Tiseo
- Abstract
Loading... -
+
P3.01-083 - Phase III Trial of PF-06439535 or Bevacizumab-EU plus Paclitaxel/Carboplatin in NSCLC
09:30 - 09:30 | Author(s): B. Desai
- Abstract
Loading... -
+
P3.01-084 - Avelumab (MSB0010718C), an Anti-PD-L1 Antibody, Evaluated in a Phase Ib Trial as a First-Line Treatment for Patients with Metastatic NSCLC
09:30 - 09:30 | Author(s): C. Verschraegen
- Abstract
Loading... -
+
P3.01-085 - Randomized Phase II Study of Docetaxel plus Bevacizumab or Pemetrexed plus Bevacizumab for Elderly Non-Squamous NSCLC (TORG1323)
09:30 - 09:30 | Author(s): T. Kozuki
- Abstract
Loading... -
+
P3.01-086 - A Phase I Dose-Escalation Study of Pirfenidone Combined with Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
09:30 - 09:30 | Author(s): M.L. Freeman-Keller
- Abstract
Loading... -
+
P3.01-087 - A Phase I Study of Exemestane with Carboplatin and Pemetrexed in Postmenopausal Women with Metastatic, Non-Squamous Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): R. Pietras
- Abstract
Loading... -
+
P3.01-088 - Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Thongprasert
- Abstract
Loading... -
+
P3.01-089 - Nab-Paclitaxel with or without CC-486 as Second-Line Therapy for NSCLC (ABOUND.2L)
09:30 - 09:30 | Author(s): R. Govindan
- Abstract
Loading... -
+
P3.01-090 - Phase 3, Double-Blind, Placebo-Controlled Study of MEDI4736 after Chemoradiation in Stage III, Locally Advanced, Unresectable NSCLC (PACIFIC)
09:30 - 09:30 | Author(s): B.C. Cho
- Abstract
Loading... -
+
P3.01-091 - Phase III Study of Front-Line Chemotherapy with TTFields for Advanced Squamous NSCLC
09:30 - 09:30 | Author(s): O. Farber
- Abstract
Loading...
-
+
P3.02 - Poster Session/ Treatment of Localized Disease – NSCLC
- Type: Poster
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 41
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.02-001 - Factors Affecting Tumor Recurrence in Early Stage Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): N. Duma
- Abstract
Loading... -
+
P3.02-002 - Long-Term Survival of Patients Undergoing Video Assisted Thoracoscopic Anatomical Resection for Stage I NSCLC Is Equivalent to Open Thoracotomy
09:30 - 09:30 | Author(s): D.M. Avella
- Abstract
Loading... -
+
P3.02-003 - Availability of the Serum CYFRA 21-1 Level with Resected Non-Small Cell Lung Cancer: The Detectability of Recurrence and the Prognostic Impact
09:30 - 09:30 | Author(s): M. Suzuki
- Abstract
Loading... -
+
P3.02-004 - PD-L1 Overexpression in NSCLC Inversely Correlated with Survival of NSCLC Patients
09:30 - 09:30 | Author(s): H. Zhong
- Abstract
Loading... -
+
P3.02-005 - Third Primary Lung Cancers: Incidence and Benefits of Surgical Therapy
09:30 - 09:30 | Author(s): D. Lee
- Abstract
Loading... -
+
P3.02-006 - How Should We Handle Elderly Patients of the Non-Small Cell Lung Cancer?
09:30 - 09:30 | Author(s): J. Okamoto
- Abstract
Loading... -
+
P3.02-007 - Survival and Prognostic Factor in Pathological N1 Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): T. Yamamoto
- Abstract
Loading... -
+
P3.02-008 - Clinical Characteristics of EML4-ALK Positive and Surgically Resected NSCLC Patients
09:30 - 09:30 | Author(s): H. Tao
- Abstract
Loading... -
+
P3.02-009 - Predictors of Prolonged Air Leak after Pulmonary Lobectomy
09:30 - 09:30 | Author(s): S. Okada
- Abstract
Loading... -
+
P3.02-010 - Tumor Recurrence of the Chest Wall after Percutaneous Hook Wire Localization
09:30 - 09:30 | Author(s): H.J. Baek
- Abstract
Loading... -
+
P3.02-011 - Evaluation of a New Chest Tube Management Using Digital Air Leak Monitoring after Lung Resection
09:30 - 09:30 | Author(s): K. Yoshida
- Abstract
Loading... -
+
P3.02-012 - Post-Surgical Recurrence of cN0-1 and pN2 Non-Small-Cell Lung Cancer in Postoperative Radiotherapy Candidates
09:30 - 09:30 | Author(s): H. Yamamoto
- Abstract
Loading... -
+
P3.02-013 - Preoperative CT-Guided Percutaneous Localization of GGO with PA Injection
09:30 - 09:30 | Author(s): H. Mu
- Abstract
Loading... -
+
P3.02-014 - COPD Being Misdiagnosed in Lung Cancer Patients with Thoracic Operation
09:30 - 09:30 | Author(s): G. Wang
- Abstract
Loading... -
+
P3.02-015 - Impact of a Lung Multidisciplinary Team Meeting
09:30 - 09:30 | Author(s): C. Lo
- Abstract
Loading... -
+
P3.02-016 - How to Manage for Unexpected Bleeding During Thoracoscopic Anatomical Pulmonary Resection
09:30 - 09:30 | Author(s): T. Miyazaki
- Abstract
Loading... -
+
P3.02-017 - Preoperative Bronchoscopy in Patients with Persistent Ground-Glass Nodule
09:30 - 09:30 | Author(s): B.W. Jhun
- Abstract
Loading... -
+
P3.02-018 - Factors Associated with Preserved Pulmonary Function in Non-Small Cell Lung Cancer Patients after Video-Assisted Thoracic Surgery
09:30 - 09:30 | Author(s): C. Lee
- Abstract
Loading... -
+
P3.02-019 - Surgery in Elderly Patients ( > 70 Years or Older) with Non-Small Lung Cancer (NSCLC). Impact of Adjuvant Chemotherapy
09:30 - 09:30 | Author(s): H. Koyi
- Abstract
Loading... -
+
P3.02-020 - What Factors Affect Postoperative Respiratory Function in the Patients Performed Sleeve Lobectomy
09:30 - 09:30 | Author(s): S. Hirayama
- Abstract
Loading... -
+
P3.02-021 - Lung Cancer Surgery: A 30 Years Monocentric Experience in Tunisia
09:30 - 09:30 | Author(s): T. Kilani
- Abstract
Loading... -
+
P3.02-022 - The Digital Monitoring of Postoperative Air Leak Patterns and Air Leak Flow Is Useful for Predicting Prolonged Air Leak after Pulmonary Resection
09:30 - 09:30 | Author(s): K. Takamochi
- Abstract
Loading... -
+
P3.02-023 - Surgical Outcomes of Lung Cancer Combined With Interstitial Pneumonia. - Single Institutional Report -
09:30 - 09:30 | Author(s): D. Taniguchi
- Abstract
Loading... -
+
P3.02-024 - Lobectomy versus Stereotactic Ablative Radiotherapy (SABR) for Stage I Non Small Cell Lung Cancer (NSCLC) in 182 Patients
09:30 - 09:30 | Author(s): V. Scotti
- Abstract
Loading... -
+
P3.02-025 - Therapeutic Lung Resection in Biliopancreatic Cancer Patients
09:30 - 09:30 | Author(s): L.A. Robinson
- Abstract
Loading... -
+
P3.02-026 - Positive or Negative Indications for Wedge Resection of Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): M. Kataoka
- Abstract
Loading... -
+
P3.02-027 - Surgical Salvage Resection for Local Recurrence after Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors
09:30 - 09:30 | Author(s): T. Bokor-Billmann
- Abstract
Loading... -
+
P3.02-028 - miMRST Wedge Resection Cured Aged, Cardiopulmonary Dysfunction Patients with Small Lung Cancer (≤2cm)
09:30 - 09:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P3.02-029 - Micro- Small Lung Cancer (≤1cm) Needs Lobectomy with Systematic Lymph Node Dissection or Sublobular Limited Resection Only?
09:30 - 09:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P3.02-030 - Linguar-Sparing Left Upper Lobectomy for Lung Cancer in a 97 Year Old Man
09:30 - 09:30 | Author(s): H. Wilson
- Abstract
Loading... -
+
P3.02-031 - Patient Outcomes following Curative-Intent Lung Resection among Non-Small Cell Lung Cancer (NSCLC) Patients in China
09:30 - 09:30 | Author(s): J. Zhou
- Abstract
Loading... -
+
P3.02-032 - Effect of Age on Adjuvant Chemotherapy after Resection of Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): X. Zhai
- Abstract
Loading... -
+
P3.02-033 - Analysis of Factors That Have Impact on Adjuvant Chemotherapy Application in Operated Stage IIA-IV Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): K. Lesniewski-Kmak
- Abstract
Loading... -
+
P3.02-034 - Utilization of Adjuvant Therapy Among Completely Resected Non-Small Cell Lung Cancer (NSCLC) Patients at Charleston Area Medical Center
09:30 - 09:30 | Author(s): S.J. Jubelirer
- Abstract
Loading... -
+
P3.02-035 - A Case of Synchronous Quintuple Lung Cancers Treated with Salvage Surgery after Treatment with Erlotinib
09:30 - 09:30 | Author(s): K. Abe
- Abstract
Loading... -
+
P3.02-036 - Predictors of Lung Fibrosis after Stereotactic Body Radiation Therapy (SBRT) for Stage I-II Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): N. Yeh
- Abstract
Loading... -
+
P3.02-037 - Robotic SBRT with Fiducial Tracking for Inoperable Peripheral Stage I NSCLC: Mature Survival and Toxicity Outcomes
09:30 - 09:30 | Author(s): N. Aghdam
- Abstract
Loading... -
+
P3.02-038 - Survival Outcomes of Stereotactic Body Radiotherapy for Early-Staged Non-Small Cell Lung Cancer: A Comparison between Different Doses
09:30 - 09:30 | Author(s): Y.K. Chik
- Abstract
Loading... -
+
P3.02-039 - Is Volumetric Rapid Arc Irradiation Superior in the Treatment of Non Small Cell Lung Cancer?
09:30 - 09:30 | Author(s): E. Bossuyt
- Abstract
Loading... -
+
P3.02-040 - PEARL: Pathologic Effect of NeoAdjuvant Stereotactic Ablative Body Radiotherapy (SABR) in Operable Early Stage Lung Cancer
09:30 - 09:30 | Author(s): J.P. Van Meerbeeck
- Abstract
Loading... -
+
P3.02-041 - Stereotactic Body Radiation Therapy Associated with Erlotinib for Localized Clonal Progression of Metastatic Non Small Cell Lung Cancer
09:30 - 09:30 | Author(s): L.K. Morikawa
- Abstract
Loading...
-
+
P3.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 38
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.03-001 - Comparison of Adjuvant Therapy Modes Following Resection in Lung Cancer Patients with Clinically (-) but Pathologically (+) N2 Disease
09:30 - 09:30 | Author(s): H. Park
- Abstract
Loading... -
+
P3.03-002 - Risk Factors and Outcomes of Pneumonectomy in Patients with Lung Cancer
09:30 - 09:30 | Author(s): M. Wong Jaen
- Abstract
Loading... -
+
P3.03-003 - Pilot Introduction of the IASLC Nodal Classification System across EBUS-TBNA, CT and PET in Staging of Non Small Cell Lung Cancer
09:30 - 09:30 | Author(s): L.F. Zhang
- Abstract
Loading... -
+
P3.03-004 - Clinicopathological Factors Associated With Postoperative Survival in Patients With Pathological Stage IB Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): M. Shimomura
- Abstract
Loading... -
+
P3.03-005 - Review of the Impact of Robotic Surgery on Pulmonary Resections Performed at a Comprehensive Cancer Center
09:30 - 09:30 | Author(s): P. Ross
- Abstract
Loading... -
+
P3.03-006 - Wide Wedge Resection with Adequate Surgical Margin for Pure GGO Lesion after Marking the Position near the Tumor with Lipiodol under a CT Scan Guide
09:30 - 09:30 | Author(s): K. Kojima
- Abstract
Loading... -
+
P3.03-007 - Salvage Surgery for Local Recurrence after Cryoablation for Non-Small Cell Lung Cancer: Importance of Diagnosis of Recurrence without Delay
09:30 - 09:30 | Author(s): S. Matsuda
- Abstract
Loading... -
+
P3.03-008 - Lung Resections: Limited Resection for Operable Lung Cancer
09:30 - 09:30 | Author(s): S. Krishnamurthy
- Abstract
Loading... -
+
P3.03-009 - A Case of Completion Pneumonectomy Performed Through Mid-Sternal Incision and Posterolateral Incision
09:30 - 09:30 | Author(s): M. Watanabe
- Abstract
Loading... -
+
P3.03-010 - Usefulness of Vessel Sealing Devices in Thoracoscopic Lobectomy for Lung Cancer
09:30 - 09:30 | Author(s): M. Toishi
- Abstract
Loading... -
+
P3.03-011 - General Anesthesia Is Not Required for Safe, Accurate Endoscopic Diagnosis of Malignant and Non-Malignant Disease in the Mediastinum
09:30 - 09:30 | Author(s): J.D. Doty
- Abstract
Loading... -
+
P3.03-012 - Prediction of Occult Lymph Node Metastasis Using Metabolic PET Parameters in Small Size Peripheral Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Jung
- Abstract
Loading... -
+
P3.03-013 - Predictive Factors for Survival in Stage IIIA (N2) NSCLC Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery
09:30 - 09:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P3.03-014 - The Impact of Post-Operative Adjuvant Chemotherapy for Resected NSCLC in the Real-World Setting: Single Center Experience
09:30 - 09:30 | Author(s): W. Liang
- Abstract
Loading... -
+
P3.03-015 - Outcomes of Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer in South of Brazil
09:30 - 09:30 | Author(s): J. Cé Coelho
- Abstract
Loading... -
+
P3.03-016 - Randomized ph II Trial of Cyclophosphamide with Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC
09:30 - 09:30 | Author(s): R.E. Sanborn
- Abstract
Loading... -
+
P3.03-017 - Interim Overall Survival of Neoadjuvant Erlotinib Intercalated with Gemcitabine/Cisplatin for IIIA N2 NSCLC Patients: A Phase II Study
09:30 - 09:30 | Author(s): Z. Chen
- Abstract
Loading... -
+
P3.03-018 - Intercalated TKI and Chemotherapy Induction in EGFR mt+ NSCLC Stage IIIA and IIIB: 3 Cases with Complete Remission in Mediastinal Lymph Nodes
09:30 - 09:30 | Author(s): F. Griesinger
- Abstract
Loading... -
+
P3.03-019 - Salvage Surgery after Definitive Chemoradiotherapy in NSCLC Patients
09:30 - 09:30 | Author(s): O. Pikin
- Abstract
Loading... -
+
P3.03-020 - Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S.H. Lee
- Abstract
Loading... -
+
P3.03-021 - Neoadjuvant Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Author(s): T. Nakagawa
- Abstract
Loading... -
+
P3.03-022 - Feasibility of Adjuvant Therapy with S-1 plus Carboplatin Followed by Maintenance Therapy with S-1 for Resected Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): N. Okumura
- Abstract
Loading... -
+
P3.03-023 - Phase III Study of Accelerated Hypofraction in CCRT of Unresectable Stage III NSCLC: Interim Analysis of KROG 0903
09:30 - 09:30 | Author(s): S. Ahn
- Abstract
Loading... -
+
P3.03-024 - Efficacy of 18 F-FDG PET/CT as Response Predictor in Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Roy
- Abstract
Loading... -
+
P3.03-025 - Fatal and near Fatal Radiation Lung Injury after Lung Cancer Treatment
09:30 - 09:30 | Author(s): C. Son
- Abstract
Loading... -
+
P3.03-026 - Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
09:30 - 09:30 | Author(s): H. Shuiyun
- Abstract
Loading... -
+
P3.03-027 - Lung Cancer: Doses to Mediastinal Structures Can Be Reduced with Volumetric Modulated Arc Therapy and Deep Inspiration Breath-Hold Radiotherapy
09:30 - 09:30 | Author(s): G.F. Persson
- Abstract
Loading... -
+
P3.03-028 - High Dose Rate (HDR) Dual Intraluminal Brachytherapy Catheter in Treatment of Bilateral Endobronchial Tumor Progression: A Case Report
09:30 - 09:30 | Author(s): L. Ladi
- Abstract
Loading... -
+
P3.03-029 - No Inferior Outcomes after Stereotactic Radiotherapy for Stage I and II NSCLC Compared with Surgery
09:30 - 09:30 | Author(s): E.A. Kastelijn
- Abstract
Loading... -
+
P3.03-030 - Evaluation of the Functional Heart Condition During Radiotherapy for Lung Cancer
09:30 - 09:30 | Author(s): Y. Ragulin
- Abstract
Loading... -
+
P3.03-031 - Predictors of Radiation Pneumonitis and Associated Changes of Pulmonary Function After Definitive Concurrent Chemoradiotherapy in NSCLC
09:30 - 09:30 | Author(s): J. Kim
- Abstract
Loading... -
+
P3.03-032 - MD Anderson Oncology Expert Advisor™: A Cognitive Clinical Decision Support Tool for Evidence-Based Multi-Disciplinary Lung Cancer Care
09:30 - 09:30 | Author(s): M.B. Antonoff
- Abstract
Loading... -
+
P3.03-033 - Management of Clinical T3-4 Locally Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): N. Yamasaki
- Abstract
Loading... -
+
P3.03-034 - Utility of Surveillance Imaging in Detection of Recurrence in Treated Stage III NSCLC Patients
09:30 - 09:30 | Author(s): O.S. Tehrani
- Abstract
Loading... -
+
P3.03-035 - Unclear Clinical Course and Treatment Options for Clear Cell Lung Cancer: A Case Series
09:30 - 09:30 | Author(s): M.K. Riaz
- Abstract
Loading... -
+
P3.03-036 - PET for Prognostic Assessment in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
09:30 - 09:30 | Author(s): U. Yilmaz
- Abstract
Loading... -
+
P3.03-037 - High Pretreatment Neutrophil-Lymphocyte Ratio: A Poor Prognostic Factor for Stage III Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): A.T. Sumbul
- Abstract
Loading... -
+
P3.03-038 - A Multi-Center Trial Comparing Standard 22-Gauge and 22-Gauge Bibevel (ProCore) Needles for Endobronchial Ultrasound
09:30 - 09:30 | Author(s): N.T. Tanner
- Abstract
Loading...
-
+
P3.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 134
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.04-001 - Exosomal RNA Based Liquid Biopsy Detection of EML4-ALK in Plasma from NSCLC Patients
09:30 - 09:30 | Author(s): K. Brinkmann
- Abstract
Loading... -
+
P3.04-002 - Correlation of ALK Status Between FISH and Immunohistochemistry in Lung Cancer: A Multicenter Study of 738 Cases in Argentina
09:30 - 09:30 | Author(s): M.J. Labanca
- Abstract
Loading... -
+
P3.04-003 - Novel Fusion Protein ALK-MPRIP Exhibits ALK Activation and Sensitivity to Crizotinib
09:30 - 09:30 | Author(s): N. Shah
- Abstract
Loading... -
+
P3.04-004 - Utility of Cytology Specimens for ALK Fusion Detected by qRT-PCR in Patients of Advanced Non Small Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Wang
- Abstract
Loading... -
+
P3.04-005 - Discrepancies between ALK FISH and Capture Based NGS Test NEOplus and Clinical Outcome with ALK TKI Therapy
09:30 - 09:30 | Author(s): R. Dziadziuszko
- Abstract
Loading... -
+
P3.04-006 - ALK Immunohistochemistry in NSCLC: Evaluation of Performance of D5F3-IHC without Using Automated Ventana System
09:30 - 09:30 | Author(s): D. Jain
- Abstract
Loading... -
+
P3.04-007 - EML4/ALK Status in Lung Cancer - A 2 Year Experience from a Tertiary Care Cancer Centre in India
09:30 - 09:30 | Author(s): S.S. Murthy
- Abstract
Loading... -
+
P3.04-008 - Detection of EML4-ALK Fusion Gene by Using Nested Long-Ranged Polymerase Chain Reaction
09:30 - 09:30 | Author(s): S. Takemoto
- Abstract
Loading... -
+
P3.04-009 - Evaluation of RT-PCR Methodology for ALK Assessment in Patients with NSCLC in Europe: Results from the ETOP Lungscape Project
09:30 - 09:30 | Author(s): I. Letovanec
- Abstract
Loading... -
+
P3.04-010 - EML4-ALK Fusion Detected by qRT-PCR Confers Similar Response to Crizotinib as Detected by FISH in Patients with Advanced NSCLC
09:30 - 09:30 | Author(s): S. Ren
- Abstract
Loading... -
+
P3.04-011 - A Validation Study for the Use of ROS-1 Immunohistochemistry in Screening for ROS-1 Translocations in Lung Cancer
09:30 - 09:30 | Author(s): P. Viola
- Abstract
Loading... -
+
P3.04-012 - Transition of HSP90-Dependent Client Proteins in ALK Rearranged Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): R. Yoshida
- Abstract
Loading... -
+
P3.04-013 - Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY
09:30 - 09:30 | Author(s): B. Oz
- Abstract
Loading... -
+
P3.04-014 - High Concordance of ALK Fusion between Primary Tumor and Paired Metastatic Lymph Node in Patients with Adenocarcinoma
09:30 - 09:30 | Author(s): L. Hou
- Abstract
Loading... -
+
P3.04-015 - Immunohistochemistry With 3 ALK Antibodies and Thymidylate Synthase Evaluation of FISH-Positive ALK-Rearranged Lung Adenocarcinomas
09:30 - 09:30 | Author(s): P. Bironzo
- Abstract
Loading... -
+
P3.04-016 - EML4-ALK Fusion in a NSCLC Patient Detected by High Sensitivity Circulating Tumor DNA Assay Empowers Targeted Therapy Decisions
09:30 - 09:30 | Author(s): N. Mohindra
- Abstract
Loading... -
+
P3.04-017 - Acinar Subtype of Lung Adenocarcinoma Is Significantly Related to EML4-ALK Translocation in Eastern European Patients
09:30 - 09:30 | Author(s): B. Zaric
- Abstract
Loading... -
+
P3.04-018 - Expression of Protein Kinase EML4-ALK Gene in Non-Small Cell Lung Cancer (NSCLC) in a University Hospital of Reference in Latin America
09:30 - 09:30 | Author(s): L.F. Sua
- Abstract
Loading... -
+
P3.04-019 - A Retrospective Analysis of Frequency of ALK Gene Rearrangement in Saudi Lung Patients
09:30 - 09:30 | Author(s): F.H. Al Dayel
- Abstract
Loading... -
+
P3.04-020 - ALK Rearrangements Epidemiology in Latin America (CLICaP)
09:30 - 09:30 | Author(s): O. Arrieta Rodriguez
- Abstract
Loading... -
+
P3.04-021 - Mutation Profiling by Targeted Next-Generation Sequencing for Diagnostics and Patient Cohort Screening in FFPE NSCLC Samples
09:30 - 09:30 | Author(s): L. La Fleur
- Abstract
Loading... -
+
P3.04-022 - The Johns Hopkins University TCGA Experience
09:30 - 09:30 | Author(s): C. Griffin
- Abstract
Loading... -
+
P3.04-023 - Exosomes and Their Potential for Detection of Lung Cancer
09:30 - 09:30 | Author(s): B. Sandfeld Paulsen
- Abstract
Loading... -
+
P3.04-024 - Lung Adenocarcinoma with Neuroendocrine Feature Revealed by Transcriptome Profiling
09:30 - 09:30 | Author(s): T. Fujiwara
- Abstract
Loading... -
+
P3.04-025 - DNA Extraction of Lung Cancer Samples for Advanced Diagnostic Testing
09:30 - 09:30 | Author(s): J. Conroy
- Abstract
Loading... -
+
P3.04-026 - Reflex Testing of EGFR and ALK in Non-Squamous Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): J.Z. Tan
- Abstract
Loading... -
+
P3.04-027 - Targeted next Generation Sequencing in Lung Cancer: Genomic Oncology in Daily Practice
09:30 - 09:30 | Author(s): D. Rangachari
- Abstract
Loading... -
+
P3.04-028 - Defining the Molecular Profile of Non-Small Cell Lung Carcinoma in a Comprehensive Cancer Center in Mexico City
09:30 - 09:30 | Author(s): C.O. Lara-Torres
- Abstract
Loading... -
+
P3.04-029 - Development of Lung Cancer Diagnosis Panel Based on the Target Sequencing Technology: A Validation Result
09:30 - 09:30 | Author(s): Y. Hwang
- Abstract
Loading... -
+
P3.04-030 - Are Experienced Physicians More Likely to Acquire Adequate Tissue Material for EGFR-Testing?
09:30 - 09:30 | Author(s): J. Berg
- Abstract
Loading... -
+
P3.04-031 - Combining CT Texture Analysis with Semantic Imaging Descriptions for the Radiogenomic Detection of EGFR and KRAS Mutations in NSCLC
09:30 - 09:30 | Author(s): J. Sorensen
- Abstract
Loading... -
+
P3.04-032 - Clinical Applications of Next Generation Sequencing on Therapeutic Decision-Making in Lung Cancer
09:30 - 09:30 | Author(s): M. Takeda
- Abstract
Loading... -
+
P3.04-033 - Screening for Driver Mutations in Caucasian Patients with Central Nervous System Metastases of Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): M. Nicoś
- Abstract
Loading... -
+
P3.04-034 - Molecular Subtyping in Advanced Non-Small Cell Lung Cancer, a Minimally Invasive Strategy with Small Volume Fine Needle Aspirates
09:30 - 09:30 | Author(s): K. Hansen
- Abstract
Loading... -
+
P3.04-035 - Genetic Heterogeneity of Actionable Genes between Primary and Metastatic Tumor in Lung Adenocarcinoma
09:30 - 09:30 | Author(s): E.Y. Kim
- Abstract
Loading... -
+
P3.04-036 - Rare Discrepancies in a Driving Gene Alteration within Histologically Heterogeneous Primary Lung Cancers
09:30 - 09:30 | Author(s): W. Zhong
- Abstract
Loading... -
+
P3.04-037 - Prevalence of NRG1 Fusions in Caucasian NSCLC Patients Determined by Fluorescence in Situ Hybridisation
09:30 - 09:30 | Author(s): A.H. Scheel
- Abstract
Loading... -
+
P3.04-038 - Molecular Topography of Early-Stage Lung Adenocarcinomas
09:30 - 09:30 | Author(s): E. Conde
- Abstract
Loading... -
+
P3.04-039 - Characterization of RNA Splicing Factor Mutations in Lung Adenocarcinoma
09:30 - 09:30 | Author(s): P.S. Choi
- Abstract
Loading... -
+
P3.04-040 - Comparison of Histology with Genome-Wide Copy Number Profiling in Patients with Metachronous or Synchronous Tumors
09:30 - 09:30 | Author(s): E. Thunnissen
- Abstract
Loading... -
+
P3.04-041 - Identification of the Functional Significance of Mutations in Lung Cancer Using the Novel Precision Cancer Analysis System
09:30 - 09:30 | Author(s): N. Peled
- Abstract
Loading... -
+
P3.04-042 - Evaluation of Texture Analysis Parameters in EGFR Mutated or ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): M.V. Bluthgen
- Abstract
Loading... -
+
P3.04-043 - Driver Mutations in Non-Small Cell Lung Cancer in Western Pennsylvania: Prevalence and Barriers to Testing
09:30 - 09:30 | Author(s): R. Rao
- Abstract
Loading... -
+
P3.04-044 - EGFR and ALK Status Influence Health Utility and Global Quality of Life Scores in Patients with Metastatic Lung Cancer
09:30 - 09:30 | Author(s): C. Labbe
- Abstract
Loading... -
+
P3.04-045 - Insights into NSCLC Molecular Testing in Central and Eastern European Countries
09:30 - 09:30 | Author(s): A. Ryska
- Abstract
Loading... -
+
P3.04-046 - Prevalence of ROS1, HER2, and BRAF Alterations in a Cohort of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients (P) Triple Negative (TN)
09:30 - 09:30 | Author(s): T. Morán
- Abstract
Loading... -
+
P3.04-047 - Prospective Study of Molecular Markers in Patients with Advanced Lung Adenocarcinoma in CEMIC. Argentina
09:30 - 09:30 | Author(s): G. Recondo
- Abstract
Loading... -
+
P3.04-048 - Rare Gene Mutations in Japanese Surgically Resected Non-Small-Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): T. Nishii
- Abstract
Loading... -
+
P3.04-049 - HER-2 Mutations in Chinese Lung Adenocarcinoma Patients with Negative EGFR Mutations
09:30 - 09:30 | Author(s): C. Zhou
- Abstract
Loading... -
+
P3.04-050 - Detection of PIK3CA Mutations, including a Novel Mutation of V344G in Exon 4, in Metastatic NSCLC: A Retrospective Study of 139 FNA Cases
09:30 - 09:30 | Author(s): D.B. Allison
- Abstract
Loading... -
+
P3.04-051 - Molecular Testing on Cell Blocks Formed From Bronchial Brush Tip Washings
09:30 - 09:30 | Author(s): A. Bonney
- Abstract
Loading... -
+
P3.04-052 - Next Generation Exome Sequencing of Archival Lung Cancer Resection Specimens
09:30 - 09:30 | Author(s): C.M. Vanderbilt
- Abstract
Loading... -
+
P3.04-053 - SPECTAlung: Screening Patients with Thoracic Tumors for Efficient Clinical Trial Access
09:30 - 09:30 | Author(s): B. Besse
- Abstract
Loading... -
+
P3.04-054 - Validation of PTEN and c-MET Status in Small Biopsy Material and Cytology for Pulmonary Adenocarcinoma
09:30 - 09:30 | Author(s): D. Pandya
- Abstract
Loading... -
+
P3.04-055 - Accurate Strategies to Detect Clinical Important Long Indels from RNA-Seq Data: EGFR as Example
09:30 - 09:30 | Author(s): Z. Sun
- Abstract
Loading... -
+
P3.04-056 - Some Lung Cancer Patients End up without an EGFR-Mutation Analysis
09:30 - 09:30 | Author(s): J. Berg
- Abstract
Loading... -
+
P3.04-057 - Pyrosequencing VS NGS KRAS and EGFR Mutation Detection: A Head to Head Comparison in Lung Adenocarcinomas
09:30 - 09:30 | Author(s): A. Papanicolau-Sengos
- Abstract
Loading... -
+
P3.04-058 - Is Targeted next Generation Sequencing Superior to Older Methods at Identifying Actionable Mutations in Selected NSCLC Patients?
09:30 - 09:30 | Author(s): W. Cooper
- Abstract
Loading... -
+
P3.04-059 - Non-Small Cell Lung Cancer Mutation Analysis in Purely Caucasian Croatian Population
09:30 - 09:30 | Author(s): M. Jakopovic
- Abstract
Loading... -
+
P3.04-060 - Non Small Cell Lung Cancer in Women: Identification of Molecular Biomarkers Towards Sex Specific Tailored Treatments
09:30 - 09:30 | Author(s): T. Vavala
- Abstract
Loading... -
+
P3.04-061 - Thoracic Oncology Clinic: Our First 200 Cases, San Jose, Costa Rica
09:30 - 09:30 | Author(s): R. Rojas Vigott
- Abstract
Loading... -
+
P3.04-062 - Application of Molecular Detection of Lung Cancer in Developing Countries
09:30 - 09:30 | Author(s): A. Zang
- Abstract
Loading... -
+
P3.04-063 - The Mutational Landscape of Pulmonary Premalignancy in the Context of Lung Adenocarcinoma
09:30 - 09:30 | Author(s): K. Krysan
- Abstract
Loading... -
+
P3.04-064 - A 24h-Single Highthroughput Assay to Identify ALK or ROS-1 Gene Fusions and EGFR Mutations in DNA from FFPE Tumor Samples or Free Circulating DNA
09:30 - 09:30 | Author(s): R. Saffroy
- Abstract
Loading... -
+
P3.04-065 - Use of next Generation Sequencing to Distinguish Origin of Poorly Differentiated Carcinomas in the Lung from Carcinomas in Other Organs
09:30 - 09:30 | Author(s): J.B. Sørensen
- Abstract
Loading... -
+
P3.04-066 - Overexpression of KIF23 Predicts Clinical Outcome in Primary Lung Cancer Patients
09:30 - 09:30 | Author(s): T. Kato
- Abstract
Loading... -
+
P3.04-067 - Inflammatory Cytokines Are Associated with the Development of Fatigue in Patients with NSCLC Treated with Definitive Radiotherapy
09:30 - 09:30 | Author(s): S. Wang
- Abstract
Loading... -
+
P3.04-068 - A Genetic Variation in a microRNA Target Site of ETS2 Gene Is Associated with Clinical Outcome of Chemotherapy in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S.Y. Lee
- Abstract
Loading... -
+
P3.04-069 - Exportin-5 (XPO5) in Lung Adenocarcinoma: A New Biomarker of Invasion in Pathology Specimens
09:30 - 09:30 | Author(s): A.M. Coffey
- Abstract
Loading... -
+
P3.04-070 - Early Prognostic Significance of Circulating Laminin γ2-Chain Fragment in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Teng
- Abstract
Loading... -
+
P3.04-071 - High Id1 Expression in Lung Cancer: A Favorable Predictor after Adjuvant Chemotherapy
09:30 - 09:30 | Author(s): Y. Cheng
- Abstract
Loading... -
+
P3.04-072 - Overexpression of CADM1 Is Associated with Poor Prognosis in Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Kikuchi
- Abstract
Loading... -
+
P3.04-073 - CXCR4 Expression Is Associated with Poor Survival in Early, Resected NSCLC
09:30 - 09:30 | Author(s): S. Otsuka
- Abstract
Loading... -
+
P3.04-074 - Prognostic Multi-Gene Molecular Assay Might Improve Identification of Pathologic Stage IB Lung Adenocarcinoma Patients at Risk for Recurrence
09:30 - 09:30 | Author(s): D. Oh
- Abstract
Loading... -
+
P3.04-075 - The Biological and Clinical Significance of Alpha-1 Antitrypsin in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): A. Szpechcinski
- Abstract
Loading... -
+
P3.04-076 - The Crux of Molecular Prognostications in NSCLC: An Optimized Biomarker Panel Fails to Outperform Clinical Parameters
09:30 - 09:30 | Author(s): D. Djureinovic
- Abstract
Loading... -
+
P3.04-077 - Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Metabolic Profiles of Mediastinal Lymph Node Aspirates
09:30 - 09:30 | Author(s): F. Socola
- Abstract
Loading... -
+
P3.04-078 - Adverse Effect of Smoking on the Intratumoral Expression of Thymidylate Synthase in Lung Cancer
09:30 - 09:30 | Author(s): S. Uematsu
- Abstract
Loading... -
+
P3.04-079 - A Panel of Genetic Polymorphism Can Predict Prognosis in Lung Cancer
09:30 - 09:30 | Author(s): S.Y. Lee
- Abstract
Loading... -
+
P3.04-080 - Combination of BMI and OLR1 in Prognosis Prediction of Patients with Squamous Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Jiang
- Abstract
Loading... -
+
P3.04-081 - Molecular Evidence of Viral DNA in Non-Small Cell Lung Cancer (NSCLC) and Normal Lung
09:30 - 09:30 | Author(s): L.A. Robinson
- Abstract
Loading... -
+
P3.04-082 - Activation of JAK1 Confers Poor Prognosis in Chinese Patients with Lung Adenocarcinoma
09:30 - 09:30 | Author(s): D. Liu
- Abstract
Loading... -
+
P3.04-083 - FGFR1, 2 and 3 Expression in Early Stage Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): M.V.D. Heuvel
- Abstract
Loading... -
+
P3.04-084 - Analytical Validation of a Proliferation-Based Molecular Signature Used as a Prognostic Marker in Early Stage Lung Adenocarcinoma
09:30 - 09:30 | Author(s): M.B. Warf
- Abstract
Loading... -
+
P3.04-085 - Anti-Glycan Antibody Profiling in De-Novo Stage IV Non-Small Cell Lung Cancer: A Pilot Study
09:30 - 09:30 | Author(s): N. Seetharamu
- Abstract
Loading... -
+
P3.04-086 - REQUITE: Validating Predictive Models and Biomarkers of RT Toxicity to Reduce Side Effects and Improve QOL
09:30 - 09:30 | Author(s): D. De Ruysscher
- Abstract
Loading... -
+
P3.04-087 - NUT Expression in Surgically Treated Small Cell, Non-Small Cell and Carcinoid Tumors of the Lung
09:30 - 09:30 | Author(s): M. Lund-Iversen
- Abstract
Loading... -
+
P3.04-088 - Matrix Proteoglycans Gene Expression Predicts Lung Cancer Patients Outcome
09:30 - 09:30 | Author(s): M.P. Rangel
- Abstract
Loading... -
+
P3.04-089 - Prospective Use of Prognostic Molecular Assay Identifies Patients at Risk for Recurrence and Changes Clinical Management in Early-Stage NSCLC
09:30 - 09:30 | Author(s): G.A. Woodard
- Abstract
Loading... -
+
P3.04-090 - Association of Nuclear Expression of RAR Beta and YY1 with Prognosis in Advance Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Muñiz-Hernández
- Abstract
Loading... -
+
P3.04-091 - Expression of Cytoplasmic ECT2 as a New Prognostic Marker for Early-Stage Lung Adenocarcinoma
09:30 - 09:30 | Author(s): Y. Murata
- Abstract
Loading... -
+
P3.04-092 - HNF4α Is a Marker for Invasive Mucinous Adenocarcinoma (IMA) and a Prognostic Factor in Stage I Lung Adenocarcinoma (LADC)
09:30 - 09:30 | Author(s): T. Eguchi
- Abstract
Loading... -
+
P3.04-093 - Neutrophil/Lymphocyte Ratios Inversely Related to Weight Change, Overall Survival; ALI Inversely Related to OS in NSCLC Pts
09:30 - 09:30 | Author(s): M. Batus
- Abstract
Loading... -
+
P3.04-094 - Hyperphosphorylation of Ribosomal Protein S6 Predicts Unfavorable Clinical Survival in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): B. Chen
- Abstract
Loading... -
+
P3.04-095 - Intensity Expression of DOK2 as a Prognostic Marker in Patients with Advanced Stage of Lung Adenocarcinoma
09:30 - 09:30 | Author(s): H. Chang
- Abstract
Loading... -
+
P3.04-096 - A Feasibility Pilot Study Testing Six DNA Methylation Markers to Improve Detection of Malignant Pleural Effusions in Lung Cancer
09:30 - 09:30 | Author(s): J.A. Boys
- Abstract
Loading... -
+
P3.04-097 - Expression of GM2 Activator Protein as a Potential Biomarker for Lung Cancer
09:30 - 09:30 | Author(s): L. Pottprommanee
- Abstract
Loading... -
+
P3.04-098 - Bis Expression in Patients with Surgically Resected Lung Cancer and Its Clinical Significance
09:30 - 09:30 | Author(s): C.D. Yeo
- Abstract
Loading... -
+
P3.04-099 - Proteome Signatures with Prognostic Impact Distinguish Non-Small Cell Lung Cancer Histology Subtypes and Metabolic States
09:30 - 09:30 | Author(s): W. Zhang
- Abstract
Loading... -
+
P3.04-100 - Chaperonin (HSP60) and Annexin 2 Are Candidate Biomarkers for Early Diagnosis of Non Small Cell Lung Carcinoma
09:30 - 09:30 | Author(s): I. Agababaoglu
- Abstract
Loading... -
+
P3.04-101 - Expression of the Endoplasmic Reticulum Stress Sensor BiP/GRP78 in Lung Adenocarcinoma: Correlations and Prognostic Significance
09:30 - 09:30 | Author(s): H. Imai
- Abstract
Loading... -
+
P3.04-102 - CC Chemokine Ligand 18 as a Biomarker for the Prediction of Radiation Induced Lung Disease (RILD)
09:30 - 09:30 | Author(s): E. Gkika
- Abstract
Loading... -
+
P3.04-103 - Evaluation of the TGF Beta Superfamily Member Activin-A as a Novel Circulating Prognostic Marker in Lung Cancer
09:30 - 09:30 | Author(s): M.A. Hoda
- Abstract
Loading... -
+
P3.04-104 - Radiation Pneumonitis: Assessment by Inflammation Imaging with Tc-99m HMPAO - Clinical Trial in Progress
09:30 - 09:30 | Author(s): H. Williams
- Abstract
Loading... -
+
P3.04-105 - SPARC, a Possible Predictive Marker to Albumin-Bound Paclitaxel (Nab-Paclitaxel) in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): K. Komiya
- Abstract
Loading... -
+
P3.04-106 - ATG7-Dependent Autophagy May Not Be Involved in Prognosis of Human NSCLC
09:30 - 09:30 | Author(s): S. Sun
- Abstract
Loading... -
+
P3.04-107 - MicroRNA Expression in Epithelial and Stromal Components of Early-Stage Non-Small Cell Lung Tumors
09:30 - 09:30 | Author(s): S.K. Patnaik
- Abstract
Loading... -
+
P3.04-108 - Differential Cellular and Molecular Response to Ablative Radiation in Non-Small Cell Lung Cancer Based on Molecular Subtype
09:30 - 09:30 | Author(s): A. Oweida
- Abstract
Loading... -
+
P3.04-109 - Validating ECOG Performance Status as a Prognostic Factor in Brazilian Patients with Pulmonary Adenocarcinoma
09:30 - 09:30 | Author(s): R.C. Bitton
- Abstract
Loading... -
+
P3.04-110 - PTPRH Hypomethylation as a Prognostic Factor in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): T. Sato
- Abstract
Loading... -
+
P3.04-111 - Gene Polymorphisms in Thoracic Tumors Receiving Cisplatin-Pemetrexed
09:30 - 09:30 | Author(s): N. Simon
- Abstract
Loading... -
+
P3.04-112 - Repeated Observation of Immune Gene Sets Enrichment in Women with Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Araujo
- Abstract
Loading... -
+
P3.04-113 - Neutrophil to Lymphocyte Ratio (NLR) at Diagnosis as a Prognostic Marker in Patients with Stage IV Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): E.D. Ricardo
- Abstract
Loading... -
+
P3.04-114 - IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma
09:30 - 09:30 | Author(s): L. Ampollini
- Abstract
Loading... -
+
P3.04-115 - A New Prognostic Index in Chinese Patients With Metastatic Non-Small Cell Lung Cancer Receiving First-Line Chemotherapy
09:30 - 09:30 | Author(s): H. Yu
- Abstract
Loading... -
+
P3.04-116 - Prognostic Role of fox-p3 Positive T-Regulatory Cells in Curatively Resected NSCLC Other than Stage IA
09:30 - 09:30 | Author(s): F. Kose
- Abstract
Loading... -
+
P3.04-117 - Clinical Characteristics and Survival Outcome of Non-Small Cell Lung Cancer According to Age
09:30 - 09:30 | Author(s): Y.S. Park
- Abstract
Loading... -
+
P3.04-118 - Expression of TS and DPD in Primary Lung Cancer
09:30 - 09:30 | Author(s): T. Shiina
- Abstract
Loading... -
+
P3.04-119 - The Decreased Serum Dopamine Level Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer and Contributes to Cancer Cell Stemness
09:30 - 09:30 | Author(s): X. Wu
- Abstract
Loading... -
+
P3.04-120 - Quantitative Immunofluorescence Based Expression Analysis in NSCLC Reveals Nuclear EZH2 as Poor Prognostic Biomarker
09:30 - 09:30 | Author(s): V. Velcheti
- Abstract
Loading... -
+
P3.04-121 - Testicular Orphan Receptor 4 (TR4) Is a Marker for Metastasis and Poor Prognosis in Non-Small Cell Lung Cancer That Drives the EMT Phenotype
09:30 - 09:30 | Author(s): L. Zhang
- Abstract
Loading... -
+
P3.04-122 - The Prognostic Significance of Galectin-3 Expression in Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Author(s): S. Pokharel
- Abstract
Loading... -
+
P3.04-123 - Serum and Pleural Fluid VEGF Levels in Advanced NSCLC
09:30 - 09:30 | Author(s): I. Gkiozos
- Abstract
Loading... -
+
P3.04-124 - High Expression of Trimethylated Histone H3 at Lysine 27 Predicts Better Prognosis in Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): X. Chen
- Abstract
Loading... -
+
P3.04-125 - Cytokine Profiles in Non-Small Cell Lung Cancer Patients Undergoing Palliative Thoracic Radiotherapy; Predictor of Response?
09:30 - 09:30 | Author(s): H.A. Eide
- Abstract
Loading... -
+
P3.04-126 - Expression of Notch1 and Notch2 in Xuanwei Female Patients with Lung Cancer and Its Clinical Significance
09:30 - 09:30 | Author(s): Y. Huang
- Abstract
Loading... -
+
P3.04-127 - Correlation Between ApoA-I and Prognosis of Advanced NSCLC Patients
09:30 - 09:30 | Author(s): C. Bai
- Abstract
Loading... -
+
P3.04-128 - Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?
09:30 - 09:30 | Author(s): S. Nakamura
- Abstract
Loading... -
+
P3.04-129 - Prognostic Factors and Biomarkers in Large Cell Carcinoma and Neuroendocrine Tumors of the Lung in the Thai Population
09:30 - 09:30 | Author(s): P. Tiraswasdichai
- Abstract
Loading... -
+
P3.04-130 - Frequency of GST Polymorphisms in Lung Cancer and Healthy Individuals from Turkey
09:30 - 09:30 | Author(s): K.C. Tertemiz
- Abstract
Loading... -
+
P3.04-131 - Relationship between Peripheral Basophil Count and Non Small Cell Lung Cancer
09:30 - 09:30 | Author(s): A. Kumar
- Abstract
Loading... -
+
P3.04-132 - Expression of nm23 and CD44v6 Proteins in Non-Small Cell Lung Cancer and Their Clinical Significance
09:30 - 09:30 | Author(s): P. Aerxiding
- Abstract
Loading... -
+
P3.04-133 - ADAM9 and EGFR Correlated With Lymph Node Metastasis Predicts Worse Prognosis in Surgically Resected Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P3.04-134 - Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and its Potential as a Biomarker
09:30 - 09:30 | Author(s): T. Lou
- Abstract
Loading...
-
+
P3.05 - Poster Session/ Prevention and Tobacco Control
- Type: Poster
- Track: Prevention and Tobacco Control
- Presentations: 12
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.05-001 - The Role of Big Tobacco in the Creation of the Expanding Epidemic of Smoking-Related Adenocarcinoma of the Lung
09:30 - 09:30 | Author(s): G. Strauss
- Abstract
Loading... -
+
P3.05-002 - Heterogeneity of Metformin Response for Lung Cancer Chemoprevention
09:30 - 09:30 | Author(s): M. Asiedu
- Abstract
Loading... -
+
P3.05-003 - Beliefs, Attitudes and Treatment Access to Lung Cancer amongst Nigeria Rural Men
09:30 - 09:30 | Author(s): M.O. Tagbarha
- Abstract
Loading... -
+
P3.05-004 - Lung Cancer Perception and Treatment Access Among Rural Smokers in Northern Nigeria
09:30 - 09:30 | Author(s): E. Odiase
- Abstract
Loading... -
+
P3.05-005 - Trends in Lung Cancer Survival in Middle East and Africa, 1995-2009
09:30 - 09:30 | Author(s): Z. Zaidi
- Abstract
Loading... -
+
P3.05-006 - Tobacco Control and the Trend of Lung Cancer Histology in Taiwan, 1994-2011
09:30 - 09:30 | Author(s): Y. Luo
- Abstract
Loading... -
+
P3.05-007 - Lung Cancer and Multiple Causes of Death, Puerto Rico, 2010
09:30 - 09:30 | Author(s): J.C. Orengo
- Abstract
Loading... -
+
P3.05-008 - Lung Cancer, Burden of Disease, Puerto Rico 2000-2010
09:30 - 09:30 | Author(s): J.C. Orengo
- Abstract
Loading... -
+
P3.05-009 - Tobacco Consumption in Cancer Patients from Colombia's Coffee Zone
09:30 - 09:30 | Author(s): P. Londno
- Abstract
Loading... -
+
P3.05-010 - Incidence and Survival of Lung Cancer at Oncosalud: Dynamic Cohort Study
09:30 - 09:30 | Author(s): A. Aguilar
- Abstract
Loading... -
+
P3.05-011 - Tumour Microenvironment: A Potential Role for Curcumin in Lung Cancer Chemoprevention
09:30 - 09:30 | Author(s): J.N. Mahale
- Abstract
Loading... -
+
P3.05-012 - Hookah Smoke Mediates Cancer-Associated Alterations in Normal Human Respiratory Epithelial Cells
09:30 - 09:30 | Author(s): Y. Xiong
- Abstract
Loading...